Tianjin MNCHIP Technologies Co., Ltd. (MNCHIP), a manufacturer specializing in microfluidic in vitro diagnostic (IVD) solutions, participated in MEDICAL JAPAN 2026 TOKYO, held from October 7 to 9 at Makuhari Messe, Japan.

At the exhibition, MNCHIP presented its point-of-care (POC) clinical chemistry solutions and connected with healthcare professionals and industry partners to explore collaboration opportunities in Japan and other international markets.

Advancing Point-of-Care Clinical Chemistry

As healthcare systems increasingly seek faster, more accessible and cost-effective diagnostic solutions, point-of-care testing is playing an important role in bringing diagnostic capabilities closer to patients.

MNCHIP develops microfluidic clinical chemistry analyzers and dedicated reagent discs designed to deliver multiple biochemical test results from a small sample volume. The platform integrates sample processing, biochemical reactions and result analysis into a compact testing workflow.

MNCHIP systems can process approximately 100 μL of whole blood and deliver results within minutes. The company’s Pointcare and Celercare product lines serve testing needs across human and veterinary diagnostics.

Connecting with Japan’s Healthcare Industry

MEDICAL JAPAN brings together companies and professionals from medical care, clinical facilities, healthcare technology and related industries. For MNCHIP, the exhibition provided an opportunity to better understand the Japanese healthcare market, exchange insights with local industry stakeholders and explore potential partnerships.

Japan’s established healthcare infrastructure and high expectations for product quality, reliability and service make local market understanding and long-term partnerships important. MNCHIP is interested in exploring cooperation opportunities, including product distribution, OEM partnerships and complementary diagnostic solutions, subject to each partner’s needs and applicable regulatory requirements.

Exploring Opportunities for International Collaboration

MNCHIP specializes in microfluidic clinical chemistry analyzers and dedicated reagent discs for human and veterinary applications. By combining its analyzer and reagent platform capabilities with partners’ market knowledge, distribution networks and application expertise, the company aims to develop practical solutions for diverse diagnostic needs.

Following the exhibition, MNCHIP will continue to explore international partnerships and opportunities for its point-of-care diagnostic solutions in Japan and other global markets.